Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype

AIDS

Volumn 12, Issue 7, 1998, Pages 737-743

  Di Stefano, Mariantonietta ^a   Monno, Laura ^a   Fiore, José R ^a   Buccoliero, Giovanni ^a   Appice, Amelia ^a   Perulli, Luisa M ^a   Pastore, Giuseppe ^a   Angarano, Gioacchino ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cerebrospinal fluid; HIV 1; Neurological disorders; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JC VIRUS; MALE; MONONUCLEAR CELL; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHENOTYPE; VIRAL LOAD;

EID: 0032493008     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199807000-00010     Document Type: Article

References (27)

1. Shaw GM, Harper ME, Hahn BH, et al.: HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985, 227:177-182.
2. Schmid P, Conrad A, Syndulko K, et al.: Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1994, 7:777-788.
3. Achim CL, Wang R, Miners DK, Wiley C: Brain viral burden in HIV-1 infection. J Neuropathol Exp Neural 1994, 53: 284-294.
4. Böni J, Emmerich BS, Leib SL, Wiestler OD, Schupbach J, Kleihues P: PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993, 43:1813-1817.
5. Di Stefano M, Gray F, Leitner T, Chiodi F: Analysis of env V3 sequences from HIV-1 infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996: 49:41-48.
6. Wiley CA, Baldwin M, Achim CL: Expression of HIV-1 regulatory and structural mRNA in the central nervous system. AIDS 1996, 10:843-847.
7. Di Stefano M, Monno L, Fiore JR, Angarano G: In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis. AIDS 1997, 11:133-135.
8. Van Kerkhoven I, Fransen K, Peeters M, et al.: Quantification of human immunodeficiency virus in plasma by RNA-PCR, viral culture, and p24 antigen detection. J Clin Microbiol 1994, 32:1669-1673.
9. Nuovo CJ, Becker J, Burk MW, et al.: In situ detection of PCR amplified HIV-1 nucleic acids in lymph nodes and peripherical blood in asymptomatic infection and advanced stage AIDS. J Acquir Immune Defic Syndr 1994, 7:916-923.
10. Phillips AN, Eron JJ, Bartlett JA, et al.: HIV-1 RNA levels and the development of clinical disease. AIDS 1996, 10:859-865.
11. Korher BTM, Kuntsman KJ, Patterson BK, et al.: Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994, 68:7467-7481.
12. Fiore JR, Bjorndal A, Peipke KA, et al.: The biological phenotype of HIV-1 is usually retained during and after sexual trasmission. Virology 1994, 204:297-303.
13. Koot M, Vos AHV, Keet RPM, et al.: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
14. Luft BJ, Hafner R: Toxoplasmosis encephalitis. AIDS 1990, 4:593-595.
15. Major EO, Ault GS: Progressive multifocal leukoencephalopathy: clinical and laboratory observation on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995, 8:184-190.
16. Simpson DM, Tagliati M: Neurologic manifestations of HIV-1 infection. Ann Intern Med 1994, 121:769-785.
17. Sönnerborg AB, Ehrnst AK, Bergdahl SKM, Pehrson PO. Skoldenberg BR, Strannergård ÖO: HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS 1988, 2:89-93.
18. Chiodi F, Albert J, Olausson E, et al.: Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV-1 infection. AIDS Res Hum Retroviruses 1988, 4:351-358.
19. Peeters MF, Colebunders RL, Van Den Abbeele K, et al.: Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and pheripheral blood. J Med Virol 1995, 47:92-96.
20. Pratt RD, Nichols S, McKinney N, Kwok S, Dankner WM, Spector SA: Virological markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996, 174:288-293.
21. Koot M, Keet IPM, Vos AHV, et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993,118:681-688.
22. Centers for Disease Control and Prevention: CDC classification system for human T-lymphotropic virus type III/lymphoadenopathy-associated virus infection. MMWR 1986: 35:336-339.
23. Donaldson YK, Bell YE, Holmes EC, Hughes ES, Brown HK, Simmonds P: In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994, 68:5991-6005.
24. Di Stefano M, Sabri F, Leitner T, et al.: Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol 1995, 33:352-355.
25. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic population. J Virol 1992, 66:1354-1360.
26. Koot M, van't Wout AB, Kootstra NA, et al.: Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J Infect Dis 1996, 173:349-354.
27. Gisslén M, Hagberg L, Svennerholm B, et al.: HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy [letter]. AIDS 1997, 11:1194